ARCT

MKT CAP:$221M

Arcturus Therapeutics Holdings Inc

Market Cap

$221M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$7.30+$1.05 (+16.80%)

Jun 5, 2026

52W High $23.1652W Low $5.90

Company Details

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and L...

CEO

—

IPO Date

Apr 16, 2020

Website

arcturusrx.com

Key Metrics TTM

Revenue

$45M

-66.4% YoY

Net Income

-$79M

EPS (Diluted)

Free Cash Flow

-$59M

Revenue / Share

$1.60

Gross Margin

91.2%

Operating Margin

-196.7%

Net Margin

-173.5%

FCF Margin

-129.9%

P/S

4.9x

P/E

Earnings Reports

Q1 2026

May 7, 2026

$610.0K-97.9%

FY 2025

Mar 3, 2026

$67M-51.4%

Q4 2025

Mar 3, 2026

$3M-85.3%

Q3 2025

Nov 12, 2025

$17M-55.8%

Q2 2025

Aug 11, 2025

$25M-46.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee